January 22, 2024 January 22, 2024Categories New TrialsNow Enrolling: The EA3211 study is evaluating a new treatment strategy for certain patients with head and neck cancerThis study is for patients with head and neck squamous cell carcinoma that has spread to just a few other areas in the body